Targeting ncRNA control networks with engineered exosomes to overcome therapy resistance in thyroid cancer.
- DOI
- 10.1016/j.critrevonc.2026.105439
- Published
- 2026 Oct
- Container
- Critical reviews in oncology/hematology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.critrevonc.2026.105439,
title = {Targeting ncRNA control networks with engineered exosomes to overcome therapy resistance in thyroid cancer.},
author = {Turaga AH and Finnerty BM and Zarnegar R and Fahey TJ 3rd},
year = {2026},
journal = {Critical reviews in oncology/hematology},
doi = {10.1016/j.critrevonc.2026.105439},
url = {https://doi.org/10.1016/j.critrevonc.2026.105439}
}RIS
TY - JOUR TI - Targeting ncRNA control networks with engineered exosomes to overcome therapy resistance in thyroid cancer. AU - Turaga AH AU - Finnerty BM AU - Zarnegar R AU - Fahey TJ 3rd PY - 2026 JO - Critical reviews in oncology/hematology DO - 10.1016/j.critrevonc.2026.105439 UR - https://doi.org/10.1016/j.critrevonc.2026.105439 ER -
APA
AH, T., BM, F., R, Z., & 3rd, F. T. (2026). Targeting ncRNA control networks with engineered exosomes to overcome therapy resistance in thyroid cancer.. Critical reviews in oncology/hematology. https://doi.org/10.1016/j.critrevonc.2026.105439
Source records
- pubmed · retrieved 2026-09-26T13:53:10.141Z